BioSpace News Archive

Lone Star Bio

Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays

Baylor Genetics announced the availability of a new Neurodevelopmental Disorders Panel for children and other patients affected by a suspected or clinically diagnosed autism spectrum disorder, intellectual disability, and/or developmental delay.

September 12, 2023

·

5 min read

Drug Development

Nuvectis Pharma Announces Initiation of the NXP900 Phase 1a Clinical Trial

Nuvectis Pharma, Inc. today announced the initiation of a Phase 1a dose escalation clinical trial of NXP900, its novel inhibitor of the SRC/YES1 kinase family (“SFK”).

September 12, 2023

·

4 min read

Genetown

Corium Announces Publication of Favorable ADLARITY® (donepezil transdermal system) Skin Irritation Clinical Trial Data

Corium, LLC announced today the publication of data reinforcing that ADLARITY (donepezil transdermal system) demonstrated favorable skin tolerability and adhesion in a placebo-controlled trial with healthy volunteers.

September 12, 2023

·

9 min read

Bio NC

Sparta Biomedical Closes an Oversubscribed Convertible Round to Advance its Breakthrough Device

Sparta Biomedical Inc., a privately held medical technology company, revolutionizing osteoarthritis treatment, is pleased to announce the close of a heavily oversubscribed convertible funding round.

September 12, 2023

·

2 min read

Lone Star Bio

Io Therapeutics, Inc., Announces Publication of Data on a Novel Compound Promoting Anti-Cancer Immune Responses

Io Therapeutics, Inc., announced the publication in Scientific Reports – Nature Publishing Group, of results from studies done with the company’s novel anti-cancer compound IRX4647, an agonist of the retinoic acid nuclear receptor gamma, discovered in the company’s oncology drug program.

September 12, 2023

·

2 min read

Inside information: Bioretec enters into the U.S. distribution agreement with Spartan Medical for the RemeOs™ screws

Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, has signed a distribution agreement for the U.S. market with Spartan Medical Inc.

September 12, 2023

·

4 min read

Drug Development

Beactica Therapeutics strengthens its preclinical development team

Beactica Therapeutics AB, the Swedish precision oncology company, announced two appointments to its preclinical development team.

September 12, 2023

·

3 min read

Relu® reaches medical quality standards with ISO13485 certification

Relu, an OEM software provider in the dental industry, obtains ISO13485 certification from EU Notified Body Kiwa Dare.

September 12, 2023

·

1 min read

Policy

CyGenica Limited Secures USFDA Approval for Orphan Drug Designation for Novel Drug Conjugate in Glioblastoma Multiforme Treatment

CyGenica Limited, a dynamic biotech startup announced a significant achievement in the battle against Glioblastoma Multiforme, a highly aggressive form of brain cancer.

September 12, 2023

·

2 min read

Genetown

First Patients Treated with TISSIUM’s Atraumatic Hernia Repair System

TISSIUM announced the first clinical use of TISSIUM’s Adhesive Hernia Repair System in patients undergoing laparoscopic ventral hernia repair as part of the ALPHA clinical study taking place in Belgium.

September 12, 2023

·

3 min read